FindTrial
Sign In

Predictive Value of Lobe-specific Mediastinal Lymph Node Sampling in Ground-glass Opacity (GGO)-dominant (=50%) Early Stage (cN0-1) Non-small Cell Lung Cancer (NSCLC)

Predictive Value of Lobe-specific Mediastinal Lymph Node Sampling in Ground-glass Opacity (GGO)-dominant (=50%) Early Stage (cN0-1) Non-small Cell Lung Cancer (NSCLC)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022097
Enrollment
Unknown
Registered
2019-03-24
Start date
2019-04-01
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

1: lobe-specific mediastinal lymph node sampling
2:systematic mediastinal lymphadenectomy

Sponsors

Thoracic Surgery Department, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Ground-glass opacity (GGO)-dominant (=50%) early stage (cN0-1) non-small cell lung cancer (NSCLC); 2. Write informed consent.

Exclusion criteria

Exclusion criteria: Surgical history of lung cancer.

Design outcomes

Primary

MeasureTime frame
FEV1;FVC;tomor location;maximum and minimum tumor diameter;Operation time;lymph node sampling time;introperative blood loss;Station of resected mediastinal lymph node;systematic mediastinal lymphnode sampling time;station of systematicly resected mediastinal lymph nodes;Intraoperative Complications;postoperative drainage volume;postoperative drainage time;Total counts and positive rate of resected lymph nodes in each station, according to pathological report;Total counts and positive rate of resected lymph nodes in each station, according to systematic mediastinal lymphadenectomy;Histologic type of tumor;Differentiation degree of tumor;Pleural invasion;vascular invasion;Postoperative Complications;—

Countries

China

Contacts

Public ContactPu Qiang

West China Hospital, Sichuan University

puqiang100@163.com+86 18980606738

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026